Compare IMRX & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMRX | ACTG |
|---|---|---|
| Founded | 2008 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.7M | 384.9M |
| IPO Year | 2021 | 1995 |
| Metric | IMRX | ACTG |
|---|---|---|
| Price | $5.27 | $4.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $17.20 | $6.00 |
| AVG Volume (30 Days) | ★ 750.7K | 209.4K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.75 | ★ 161.11 |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | ★ $12,004,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.10 | $2.99 |
| 52 Week High | $10.08 | $5.22 |
| Indicator | IMRX | ACTG |
|---|---|---|
| Relative Strength Index (RSI) | 45.18 | 55.75 |
| Support Level | $4.66 | $4.80 |
| Resistance Level | $5.36 | $5.18 |
| Average True Range (ATR) | 0.40 | 0.15 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 9.43 | 56.83 |
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.